0910-AC25 200604 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Exception From General Requirements for Informed Consent; Request for Comments and Information This interim final rule will add an exception from the general requirement for informed consent in certain circumstances involving the use of investigational in vitro diagnostic devices to identify chemical, biological, radiological, or nuclear agents in a potential terrorist event or other public health emergency. Other Significant Previously Published in The Unified Agenda Final Rule Stage No No 21 CFR 50.23 21 USC 321 21 USC 351 21 USC 352 21 USC 355 21 USC 360 21 USC 360bbb 21 USC 360c 21 USC 360d 21 USC 360e 21 USC 360f 21 USC 360h 21 USC 360i 21 USC 360j 21 USC 371 21 USC 381 No Interim Final Rule 06/00/2006 No No State NA Not Collected Gail Schmerfeld 0910 Food and Drug Administration FDA 877 287-1373 240 276-3904 gail.schmerfeld@fda.hhs.gov 14-101-11, 9200 Corporate Boulevard, Rockville MD 20850